Effects and cost-effectiveness of pharmacogenetic screening for CYP2D6 among older adults starting therapy with nortriptyline or venlafaxine: study protocol for a pragmatic randomized controlled trial (CYSCEtrial)

被引：0
|
作者：
Elizabeth JJ Berm
Eelko Hak
Maarten Postma
Marjolein Boshuisen
Laura Breuning
Jacobus RBJ Brouwers
Ton Dhondt
Paul AF Jansen
Rob M Kok
Jan G Maring
Rob van Marum
Hans Mulder
Richard C Oude Voshaar
Arne J Risselada
Harry Venema
Liesbeth Vleugel
Bob Wilffert
机构：
[1] Groningen Institute of Pharmacy,Department of Epidemiology
[2] University of Groningen,Departement of Old Age and Clinical Psychiatry
[3] Unit of Pharmacotherapy & Pharmaceutical Care,Department of Geriatric Medicine and Expertise Centere Pharmacotherapy in Old Persons
[4] Groningen Institute of Pharmacy,Department of Old
[5] University of Groningen,age Psychiatry
[6] Unit of Pharmacoepidemiology & Pharmacoeconomics,Department of Old Age
[7] University Medical Center Groningen,Laboratory for Drug Analysis & Toxicology
[8] Lentis,Department of Geriatric Medicine
[9] Dignis,Department of General Practice & Elderly Care Medicine
[10] Reinier van Arkel Group,Clinical Pharmacy
[11] UMC Utrecht,Department of Old Age Psychiatry
[12] GGZ-Noord Holland Noord,Department of Old Age Psychiatry
[13] Parnassia Psychiatric Institute,Department of Clinical Pharmacy and Pharmacology
[14] Diaconessen Hospital Meppel & Bethesda Hospital Hoogeveen,undefined
[15] Jeroen Bosch Hospital,undefined
[16] VU University,undefined
[17] Wilhelmina Hospital Assen,undefined
[18] University of Groningen,undefined
[19] University Medical Center Groningen,undefined
[20] University Center for Psychiatry,undefined
[21] GGZ Friesland,undefined
[22] GGZ inGeest,undefined
[23] University Medical Center Groningen,undefined
来源：
Trials | / 16卷
关键词：
CYP2D6; Pharmacogenetics; Depression; Nortriptyline; Venlafaxine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 21 条
  • [1] Effects and cost-effectiveness of pharmacogenetic screening for CYP2D6 among older adults starting therapy with nortriptyline or venlafaxine: study protocol for a pragmatic randomized controlled trial (CYSCEtrial)
    Berm, Elizabeth J. J.
    Hak, Eelko
    Postma, Maarten
    Boshuisen, Marjolein
    Breuning, Laura
    Brouwers, Jacobus R. B. J.
    Dhondt, Ton
    Jansen, Paul A. F.
    Kok, Rob M.
    Maring, Jan G.
    van Marum, Rob
    Mulder, Hans
    Voshaar, Richard C. Oude
    Risselada, Arne J.
    Venema, Harry
    Vleugel, Liesbeth
    Wilffert, Bob
    TRIALS, 2015, 16
  • [2] Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine A Pragmatic Randomized Controlled Trial (CYSCE Trial)
    van der Schans, Jurjen
    Hak, Eelko
    Postma, Maarten
    Breuning, Laura
    Brouwers, Jacobus R. B. J.
    Ditters, Kaspar
    Jansen, Paul A. F.
    Kok, Rob M.
    Maring, Jan G.
    van Marum, Rob
    Mulder, Hans
    Nanninga, Jaap
    Voshaar, Richard C. Oude
    Risselada, Arne J.
    Vleugel, Liesbeth
    Stek, Max
    van Schaik, Ron H. N.
    Berm, Elizabeth J. J.
    Wilffert, Bob
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2019, 39 (06) : 583 - 590
  • [3] COST-EFFECTIVENESS OF CYP2D6 GENOTYPING IN OLDER DEPRESSED PATIENTS, STARTING WITH NORTRIPTYLINE THERAPY
    Berm, E. J.
    Gout-Zwart, J. J.
    Luttjeboer, J.
    Maring, J. G.
    Wilffert, B.
    Postma, M. J.
    VALUE IN HEALTH, 2015, 18 (03) : A107 - A107
  • [4] A Model Based Cost-Effectiveness Analysis of Routine Genotyping for CYP2D6 among Older, Depressed Inpatients Starting Nortriptyline Pharmacotherapy
    Berm, Elizabeth J. J.
    Gout-Zwart, Judith J.
    Luttjeboer, Jos
    Wilffert, Bob
    Postma, Maarten J.
    PLOS ONE, 2016, 11 (12):
  • [5] Intermediate metabolizer: increased side effects in psychoactive drug therapy. The key to cost-effectiveness of pretreatment CYP2D6 screening?
    Laika, B.
    Leucht, S.
    Heres, S.
    Steimer, W.
    PHARMACOGENOMICS JOURNAL, 2009, 9 (06): : 395 - 403
  • [6] Intermediate metabolizer: increased side effects in psychoactive drug therapy. The key to cost-effectiveness of pretreatment CYP2D6 screening?
    B Laika
    S Leucht
    S Heres
    W Steimer
    The Pharmacogenomics Journal, 2009, 9 : 395 - 403
  • [7] Study protocol: cost-effectiveness of multidisciplinary nutritional support for undernutrition in older adults in nursing home and home-care: cluster randomized controlled trial
    Anne Marie Beck
    Annette Gøgsig Christensen
    Birthe Stenbæk Hansen
    Signe Damsbo-Svendsen
    Tina Kreinfeldt Skovgaard Møller
    Eigil Boll Hansen
    Hans Keiding
    Nutrition Journal, 13
  • [8] Study protocol: cost-effectiveness of multidisciplinary nutritional support for undernutrition in older adults in nursing home and home-care: cluster randomized controlled trial
    Beck, Anne Marie
    Christensen, Annette Gogsig
    Hansen, Birthe Stenbk
    Damsbo-Svendsen, Signe
    Moller, Tina Kreinfeldt Skovgaard
    Hansen, Eigil Boll
    Keiding, Hans
    NUTRITION JOURNAL, 2014, 13
  • [9] Effectiveness and cost-effectiveness of a collaborative deprescribing intervention of proton-pump-inhibitors on community-dwelling older adults: Protocol for the C-SENIoR, a pragmatic non-randomized controlled trial
    Romano, Sonia
    Monteiro, Luis
    Guerreiro, Jose Pedro
    Simoes, Joao Braga
    Rodrigues, Antonio Teixeira
    Lunet, Nuno
    Perelman, Julian
    PLOS ONE, 2024, 19 (03): : 1 - 15
  • [10] Cost-effectiveness Analysis of CYP2D6*10 Pharmacogenetic Testing to Guide the Adjuvant Endocrine Therapy for Postmenopausal Women with Estrogen Receptor Positive Early Breast Cancer in China
    Xiaoxia Wei
    Hong Sun
    Jie Zhuang
    Xiuhua Weng
    Bin Zheng
    Qiwang Lin
    Guifeng Zhang
    Jiaqin Cai
    Clinical Drug Investigation, 2020, 40 : 25 - 32
123